ICU PE Ratio & Valuation,Is ICU Overvalued

ICU Relative Valuation

ICU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICU is overvalued; if below, it's undervalued.

Historical Valuation

SeaStar Medical Holding Corp (ICU) is now in the Fair zone, suggesting that its current forward PS ratio of 8.02 is considered Fairly compared with the five-year average of -0.89. The fair price of SeaStar Medical Holding Corp (ICU) is between 0.27 to 0.50 according to relative valuation methord.

Relative Value

Fair Zone

0.27-0.50

Current Price：0.32

Fair

-0.74

0.00

EV/EBITDA

SeaStar Medical Holding Corp. (ICU) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.13

EV/EBIT

SeaStar Medical Holding Corp. (ICU) has a current EV/EBIT of 0.13. The 5-year average EV/EBIT is -1.10. The thresholds are as follows: Strongly Undervalued below -4.77, Undervalued between -4.77 and -2.94, Fairly Valued between 0.73 and -2.94, Overvalued between 0.73 and 2.56, and Strongly Overvalued above 2.56. The current Forward EV/EBIT of 0.13 falls within the Historic Trend Line -Fairly Valued range.

8.02

SeaStar Medical Holding Corp. (ICU) has a current PS of 8.02. The 5-year average PS is 25.76. The thresholds are as follows: Strongly Undervalued below -72.47, Undervalued between -72.47 and -23.36, Fairly Valued between 74.88 and -23.36, Overvalued between 74.88 and 123.99, and Strongly Overvalued above 123.99. The current Forward PS of 8.02 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

SeaStar Medical Holding Corp. (ICU) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.37. The thresholds are as follows: Strongly Undervalued below -2.19, Undervalued between -2.19 and -1.28, Fairly Valued between 0.54 and -1.28, Overvalued between 0.54 and 1.44, and Strongly Overvalued above 1.44. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

SeaStar Medical Holding Corp. (ICU) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

SeaStar Medical Holding Corp (ICU) has a current Price-to-Book (P/B) ratio of 0.97. Compared to its 3-year average P/B ratio of -0.87 , the current P/B ratio is approximately -211.47% higher. Relative to its 5-year average P/B ratio of -6.27, the current P/B ratio is about -115.44% higher. SeaStar Medical Holding Corp (ICU) has a Forward Free Cash Flow (FCF) yield of approximately -122.63%. Compared to its 3-year average FCF yield of -91.40%, the current FCF yield is approximately 34.16% lower. Relative to its 5-year average FCF yield of -87.66% , the current FCF yield is about 39.89% lower.

0.97

P/B

Median3y

-0.87

Median5y

-6.27

-122.63

FCF Yield

Median3y

-91.40

Median5y

-87.66

Competitors Valuation Multiple

The average P/S ratio for ICU's competitors is 8.98, providing a benchmark for relative valuation. SeaStar Medical Holding Corp Corp (ICU) exhibits a P/S ratio of 8.02, which is -10.7% above the industry average. Given its robust revenue growth of 169.12%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of ICU decreased by 83.44% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 68.00K to 183.00K.

The secondary factor is the Margin Expansion, contributed -71.19%to the performance.

Overall, the performance of ICU in the past 1 year is driven by Revenue Growth. Which is more sustainable.

169.12%

68.00K → 183.00K

Revenue Growth

-71.19%

-6.59K → -1.90K

Margin Expansion

-181.37%

0.38 → -0.31

P/E Change

-83.44%

1.94 → 0.32

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is SeaStar Medical Holding Corp (ICU) currently overvalued or undervalued?

What is SeaStar Medical Holding Corp (ICU) fair value?

ICU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of SeaStar Medical Holding Corp (ICU) is between 0.27 to 0.50 according to relative valuation methord.

How does ICU's valuation metrics compare to the industry average?

The average P/S ratio for ICU's competitors is 8.98, providing a benchmark for relative valuation. SeaStar Medical Holding Corp Corp (ICU) exhibits a P/S ratio of 8.02, which is -10.70% above the industry average. Given its robust revenue growth of 169.12%, this premium appears sustainable.

What is the current P/B ratio for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

As of Dec 15 2025, SeaStar Medical Holding Corp (ICU) has a P/B ratio of 0.97. This indicates that the market values ICU at 0.97 times its book value.

What is the current FCF Yield for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

As of Dec 15 2025, SeaStar Medical Holding Corp (ICU) has a FCF Yield of -122.63%. This means that for every dollar of SeaStar Medical Holding Corp’s market capitalization, the company generates -122.63 cents in free cash flow.

What is the current Forward P/E ratio for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

As of Dec 15 2025, SeaStar Medical Holding Corp (ICU) has a Forward P/E ratio of -0.74. This means the market is willing to pay $-0.74 for every dollar of SeaStar Medical Holding Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

As of Dec 15 2025, SeaStar Medical Holding Corp (ICU) has a Forward P/S ratio of 8.02. This means the market is valuing ICU at $8.02 for every dollar of expected revenue over the next 12 months.

ICU Valuation

ICU Valuation

ICU Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is SeaStar Medical Holding Corp (ICU) currently overvalued or undervalued?

What is SeaStar Medical Holding Corp (ICU) fair value?

How does ICU's valuation metrics compare to the industry average?

What is the current P/B ratio for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

What is the current FCF Yield for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

What is the current Forward P/E ratio for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?

What is the current Forward P/S ratio for SeaStar Medical Holding Corp (ICU) as of Dec 15 2025?